Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy

Although high-dose cisplatin is the standard regimen of concurrent chemoradiotherapy (CCRT) for locally advanced head and neck squamous cell carcinoma (HNSCC), varying levels of patient tolerance towards cisplatin have been reported, and the predictive factors of cisplatin tolerance remain to be elu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: NAKANO, KENJI, SATO, YASUYOSHI, TOSHIYASU, TAKASHI, SATO, YUKIKO, INAGAKI, LINA, TOMOMATSU, JUNICHI, SASAKI, TORU, SHIMBASHI, WATARU, FUKUSHIMA, HIROFUMI, YONEKAWA, HIROYUKI, MITANI, HIROKI, KAWABATA, KAZUYOSHI, TAKAHASHI, SHUNJI
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734196/
https://ncbi.nlm.nih.gov/pubmed/26893880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.687
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados